Tiedemann Advisors’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
Sell
-610
Closed -$338K 461
2017
Q2
$338K Buy
610
+15
+3% +$8.31K 0.02% 351
2017
Q1
$394K Buy
595
+42
+8% +$27.8K 0.03% 298
2016
Q4
$185K Buy
+553
New +$185K 0.02% 301